PATENT CLAIM ANALYSIS

Application Number: 15875230
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["548", "954000"]

Abstract:
There is provided the use as reducing agents of alpha-hydroxycarbonyl compounds capable of forming cyclic dimers. There is also provided corresponding methods of reducing reducible compounds, particularly reduction-activated prodrugs. Examples of the alpha-hydroxycarbonyl compounds used are dihydroxyacetone, glycolaldehyde, glyceraldehyde, erythrose, xylulose, erythrulose or 3-hydroxy-2-butanone.

Claim (Index 73):
A topical pharmaceutical composition comprising 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide and a topically-acceptable adjuvant, diluent or carrier.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 86.0
- Lexical Diversity: 1.51429
- Patent Class: 548.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14628980', '12159363', '10099830', '09445865', '15038345']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.691724787007027
- 35 USC 102 Novelty (BERT): 0.5736244921756496
- Combined Prediction Score: 0.6799147575238893
- Mean Citation Score: 312.701182
- Max Citation Score: 457.4453
- Similarity Product: 401.0935197841644

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test